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Abstract
A 127-kDa protein was identified as a component of the H/oligopeptide transport system in brush-border membrane
vesicles from rabbit small intestine by photoaffinity labeling with [3H]cephalexin and further photoreactive L-lactam
antibiotics and dipeptides. Reconstitution of stereospecific transport activity revealed the involvement of the 127-kDa
protein in H-dependent transport of oligopeptides and orally active K-amino-L-lactam antibiotics (Kramer et al., Eur. J.
Biochem. 204 (1992) 923^930). H-Dependent transport activity was found in all segments of the small intestine
concomitantly with the specific labeling of the 127-kDa protein. By enzymatic deglycosylation, fragments of Mr 116 and
95 kDa were obtained from the 127-kDa protein with endoglucosidase F and N-glycanase, whereas with endoglucosidase H,
a fragment of Mr 116 kDa was formed. These findings indicate that the photolabeled 127-kDa protein is a
microheterogenous glycoprotein. Surprisingly, it was found that the solubilized and purified 127-kDa protein showed
enzymatic sucrase and isomaltase activity. Inhibition of the glucosidase activities with the glucosidase inhibitor HOE 120
influenced neither H/oligopeptide transport nor photoaffinity labeling of the 127-kDa protein. With polyclonal antibodies
raised against the purified 127-kDa protein, a coprecipitation of sucrase activity and the photolabeled 127-kDa L-lactam
antibiotic binding protein occurred. Target size analysis revealed a functional molecular mass of 165 þ 17 kDa for
photoaffinity labeling of the 127-kDa protein, suggesting a homo- or heterodimeric functional structure of the 127-kDa
protein in the brush-border membrane. These findings indicate that the H/oligopeptide binding protein of Mr 127 000 is
closely associated with the sucrase/isomaltase complex in the enterocyte brush-border membrane. ß 1998 Elsevier Science
B.V. All rights reserved.
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1. Introduction
Peptide-derived drugs, such as K-amino-L-lactam
antibiotics, angiotensin-converting enzyme inhibitors
or renin inhibitors, are taken up in the small intestine
by a saturable H-dependent active transport system
[1^13]. Physiologically this nutrient transport system
absorbs small peptides formed by enzymatic hydrol-
ysis of ingested proteins [14^16]. The presence of H/
oligopeptide transporters in the intestine and the kid-
ney plays an important physiological role in the
maintenance of protein nutrition and nitrogen bal-
ance. Our laboratory has identi¢ed putative protein
components of the H-dependent uptake system for
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oligopeptides and L-lactam antibiotics in the small
intestine and the kidney by photoa⁄nity labeling,
protein puri¢cation and reconstitution techniques.
In the brush-border membrane of enterocytes from
rabbit, rat and pig small intestine, an integral mem-
brane protein of apparent Mr 127 000 was speci¢cally
labeled by photoreactive derivatives of penicillins,
cephalosporins and dipeptides [5,6,12,13,17^20],
whereas in rat renal cortex, two binding proteins of
Mr 130 000 and 95 000 were labeled [21,22]. With a
di¡erent technique (a⁄nity labeling with phenyliso-
thiocyanate in the absence and presence of cephalex-
in) the speci¢c binding of K-amino-L-lactam anti-
biotics to a 127-kDa protein was also demon-
strated [12]. By puri¢cation, immunoprecipitation
with polyclonal antibodies [19,23] and by stereospe-
ci¢c reconstitution of transport activity [20], the in-
volvement of the 127-kDa protein in the transport of
oligopeptides and peptide-derived drugs across the
enterocyte brush-border membrane was demon-
strated. Our ¢ndings were recently con¢rmed by pub-
lications by Miyazaki et al. Using ceftibuten-a⁄nity
chromatography, two proteins of Mr 127 and 117
kDa [24] were puri¢ed from rat intestinal brush-bor-
der membranes showing H-dependent oligopeptide
transport after reconstitution in proteoliposomes
[24,25].
With a di¡erent methodology, other research
groups have identi¢ed by expression cloning H/oli-
gopeptide transporters from the small intestine,
PepT1 [26^28] and from the kidney, PepT2 [29,30].
Depending on the cloning strategy used, structurally
quite di¡erent proteins were identi¢ed in small intes-
tine as H/oligopeptide transporters, PepT1 [26] by
Hediger’s group and HPT-1 by Dantzig and co-
workers [28]. These two proteins exhibited H-de-
pendent uptake of dipeptides and K-amino-L-lactam
antibiotics and showed the characteristics of H/oli-
gopeptide cotransport in transfected cells. However,
both proteins do not show any sequence or structure
homology to each other and are thus completely dif-
ferent proteins. The transporter PepT1 has 748 ami-
no acids showing 12 putative transmembrane do-
mains [26] whereas HPT-1 has 832 amino acids
with only one transmembrane domain as well as
highly conserved regions that are found in the cad-
herin superfamily [28]. Therefore, three di¡erent pro-
teins located in the brush-border membrane of mam-
malian small intestinal enterocytes were identi¢ed
exhibiting the characteristics of H/oligopeptide co-
transport. In the present paper, we describe the fur-
ther biochemical characterization of the 127-kDa oli-
gopeptide transporter from rabbit small intestine as a
component of a protein complex with sucrase/isomal-
tase.
2. Materials and methods
[Phenyl-4(n)-3H]benzylpenicillin (speci¢c radioac-
tivity 8^31 Ci/mmol) was obtained from Amersham
(Amersham Buchler, Braunschweig, Germany). [Phe-
nyl-3H]cephalexin (speci¢c radioactivity 1.5 Ci/
mmol) was synthesized at Hoechst Aktiengesellschaft
by Dr. Raymond Oekonomopulos). D-[U-14C]Glu-
cose (speci¢c radioactivity 258.5 mCi/mmol) and
[G-3H]taurocholic acid (speci¢c radioactivity 2.1 Ci/
mmol) were from Du Pont de Nemours (NEN Divi-
sion, Dreieich, Germany). L-Cephalexin was synthe-
sized at Hoechst Aktiengesellschaft. D-Cephalexin,
L-lactam antibiotics and marker proteins for the de-
termination of molecular masses in electrophoresis
were from Sigma (Munich, Germany). Triton X-
100, Triton X-114, n-octylglycoside, Serva Blue R
250 and materials for electrophoresis were obtained
from Serva (Heidelberg, Germany). Endoglycosidase
F, (New England Nuclear, (NEC-150) (EC 3.2.1.96))
and endoglycosidase H (EC 3.2.1.96) was from Sig-
ma (Munich, Germany) whereas N-glycanase (EC
3.5.1.52) was from Genzyme (Cambridge, MA).
Wheat-germ lectin agarose, wheat-germ lectin Sepha-
rose and Mono-S columns (HR 5/5) were obtained
from Pharmacia (Pharmacia LKB Biotechnologie,
Freiburg, Germany). Cellulose nitrate ¢lters for
transport studies (ME 25; 0.45 Wm; 25 mm diameter)
were from Schleicher and Schuell (Dassel, Germany)
whereas the scintillators Quickszint 501, Quickszint
361, Unisolve I and the tissue solubilizer Biolute S
were products of Zinsser Analytic (Frankfurt, Ger-
many). Kits 3359 and 3394 for the determination of
the activity of the marker enzymes aminopeptidase N
(3359) and Q-glutamyltransferase (3394) and solvents
for HPLC were obtained from Merck (Darmstadt,
Germany). Protein was determined according to
Bradford [31] using the Bio-Rad Kit (Bio-Rad, Mun-
ich, Germany). Pre¢lled columns for HPLC chroma-
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tography (Nucleosil 120, 7 Wm, C18) were obtained
from Macherey-Nagel (Du«ren, Germany). All other
materials were of analytical grade and obtained from
the usual commercial sources.
2.1. Preparation of brush-border membrane vesicles
Brush-border membrane vesicles were prepared
from the small intestines of male white rabbits by
the Mg2-precipitation method as described previ-
ously [5^7,17^21]. The functional integrity of the
vesicles was determined by measurement of the
Na-dependent uptake of D-glucose; after a 15-s in-
cubation, a 25^40-fold overshoot compared to equi-
librium was obtained. For the anatomical localiza-
tion of the H/oligopeptide transport system along
the duodenum^ileum axis the entire small intestine
between the pylorus and the caecum was removed,
rinsed with ice-cold sodium phosphate-bu¡ered sa-
line and divided into 8 segments of equal length,
numbered 1^8, proximal to distal. From each seg-
ment, brush-border membrane vesicles were prepared
and the enrichment in the marker enzyme amino-
peptidase N (EC 3.4.11.2) was determined. The
vesicles were used for transport and labeling experi-
ments immediately after preparation. In all other ex-
periments, jejunal vesicles were prepared from seg-
ments 2 to 6.
2.2. Transport measurements
The uptake of cephalexin and D-[U-14C]glucose
was measured by the membrane ¢ltration method
as described [5^7, 17^21]. The concentration of ceph-
alexin in the incubation mixtures was 2 mM. Uptake
studies with D-glucose were performed with 1 WCi
D-[U-14C]glucose corresponding to a ¢nal concentra-
tion of 19.34 WM of D-glucose for each determination
and bile acid transport was measured for 1 min with
50 WM (0.75 WCi) [3H]taurocholate. The composition
of the incubation media is given in the legends to
¢gures. The transport studies were carried out at
30‡C and initiated by mixing of 10 Wl of brush-bor-
der membrane vesicles (100 Wg of protein) with 90 Wl
of medium containing the substrate. After 1 min of
incubation, transport was stopped by the addition of
1 ml of ice-cold stop solution (10 mM Tris-HEPES
bu¡er (pH 7.4)/140 mM KCl) and the suspension
was immediately pipetted onto the middle of a pre-
wetted ¢lter. After washing with 5 ml of ice-cold stop
solution, the cephalexin taken up by the vesicles was
determined by HPLC after extraction of the ¢lters
with water, using a Waters HPLC chromatography
system (Waters 840 Chromatography Data Station,
Waters 490 E Programmable Multiwavelength De-
tector, WISP Model 712 Sample Processor, Model
510 HPLC pumps). Analysis was performed in a
Bischo¡ 2504 mm column (Bischo¡, Leonberg, Ger-
many) ¢lled with LiChrosorb RP 18 (7 Wm, Merck,
Darmstadt, Germany) using a mixture of solvent A
(30 mM sodium phosphate bu¡er (pH 6.2)/10 mM
tetraethylammonium chloride) and solvent B (400 g
of solvent A and 468 g of acetonitrile) at a ratio (v/v)
of 73% solvent A and 27% solvent B. For the de-
termination of radioactively labeled substrates,
the ¢lters were dissolved in 4 ml of scintillator
Quickzint 361. Radioactivity was measured by liquid
scintillation counting in a Packard TriCarb 2000
counter (Packard, Downers Grove, IL, USA); cor-
rections were made for quenching and eventual
chemiluminescence. Each transport experiment was
performed at least three times with di¡erent mem-
brane preparations. The uptake values for cephalexin
are determined in triplicate and are given as
mean þ S.D.
2.3. Photoa⁄nity labeling
For photoa⁄nity labeling, brush-border mem-
brane vesicles, suspended in 10 mM citrate/Tris bu¡-
er (pH 6.0)/140 mM KCl were incubated with
the indicated amounts of [3H]benzylpenicillin or
[3H]cephalexin for 5 min in the dark. Subsequently,
the vesicle suspension was irradiated for 2 min at a
wavelength of 254 nm with [3H]benzylenicllin or for
5 min at 300 nm with [3H]cephalexin at 20‡C in a
Rayonet RPR 100 photochemical reactor equipped
with 16 RPR 2530 Aî or 16 RPR 3000 Aî lamps. After
photoa⁄nity labeling the membrane suspensions
were diluted with ice-cold bu¡er (10 mM sodium
phosphate (pH 7.4/300 mM mannitol/4 mM PMSF/
4 mM EDTA/4 mM iodacetamide) and subsequently
centrifuged at 48 000Ug for 30 min. The membrane
proteins in the resulting pellet were either analyzed
by SDS-PAGE after precipitation of proteins or used
for chromatography.
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2.4. SDS-PAGE and detection of radioactivity
SDS-PAGE was performed on discontinuous SDS
slab gels (200U140U1.5 mm) as previously described
[5,6,23,32]. The proteins were dissolved in 70 Wl of
SDS sample bu¡er (62.5 mM Tris-HCl (pH 6.8)/2%
SDS/10% glycerol/5% 2-mercaptoethanol/0.001%
Bromophenol blue). After centrifugation at
15 000Ug for 5 min, the clear supernatants were sub-
mitted to SDS-PAGE gel electrophoresis on 7.5^9%
gels. After ¢xing and staining the gels were scanned
with a densitometer CD50 (DESAGA, Heidelberg,
Germany). For the detection of radioactively labeled
polypeptides on SDS gels, the gel tracks were cut
into 2-mm slices. After digestion of the polypeptides
with 250 Wl of Biolute S, 4 ml of scintillator Quicks-
zint 501 was added and radioactivity was measured
by liquid scintillation counting using a Tricarb 2000
counter (Packard Instruments).
2.5. Puri¢cation of the 127-kDa binding protein for
oligopeptides/L-lactam antibiotics
The 127-kDa binding protein for oligopeptides/L-
lactam antibiotics was puri¢ed from solubilized rab-
bit jejunal brush-border membrane vesicles after
photoa⁄nity labeling with [3H]benzylpenicillin by
wheat-germ lectin chromatography and subsequent
cation-exchange chromatography on Mono-S HR
5/5 columns as described [19,23]. The fractions were
analyzed for radioactivity, enzymatic activities of
aminopeptidase N, sucrase and isomaltase and ali-
quots were submitted to SDS-PAGE with subsequent
determination of the distribution of radioactively la-
beled 127-kDa protein in the di¡erent fractions. The
activity of sucrase and isomaltase was determined
according to Dahlqvist [33] using sucrose and isomal-
tose as substrates, respectively.
2.6. Determination between integral and peripheral
membrane proteins
To determine whether the photolabeled oligopep-
tide binding proteins are integral or peripheral mem-
brane proteins, the following investigations were per-
formed using membrane vesicles photolabeled with
[3H]benzylpenicillin.
2.6.1. Alkaline extraction
Brush-border membrane vesicles (340 Wg of pro-
tein) suspended in 300 Wl of Tris-HEPES bu¡er
(pH 7.4)/300 mM mannitol were centrifuged at
48 000Ug for 30 min. The supernatant was dis-
carded, and the pellet was resuspended in 300 Wl of
100 mM sodium hydrogen carbonate solution con-
taining 4 mM EDTA and kept at 0‡C for 30 min.
After centrifugation at 48 000Ug for 30 min, the
supernatant and the pellet were carefully separated,
delipidated with chloroform/methanol [23] and sub-
mitted to SDS-PAGE.
2.6.2. Solubilization with Triton X-100
Brush-border membrane vesicles (230 Wg of pro-
tein) were suspended in 200 Wl of 10 mM Tris-
HEPES bu¡er (pH 7.4)/300 mM mannitol/0.1% (v/
v) Triton X-100 and kept at 0‡C for 30 min. After
centrifugation at 48 000Ug for 30 min, both the
supernatant and the pellet were delipidated and sub-
mitted to SDS-PAGE.
2.6.3. Treatment with Triton X-114
Treatment of membranes with Triton X-114 was
performed using a modi¢cation of the method de-
scribed by Bordier [34]. Brush-border membrane
vesicles (340 Wg of protein) were suspended in 250
Wl of 10 mM Tris-HCl bu¡er (pH 7.3)/1% (v/v) Tri-
ton X-114/150 mM NaCl and kept at 0‡C for 15 min.
After centrifugation at 48 000Ug for 30 min at 4‡C,
the supernatant was carefully overlaid to a cushion
of 100 Wl of 10 mM Tris-HCl bu¡er (pH 7.3)/6%
(w/v) sucrose/150 mM NaCl/0.1% (v/v) Triton X-
114 in an Eppendorf tube. After 5 min of incubation
at 37‡C, the probe was centrifuged at 3000Ug for
5 min. The upper detergent-poor phase containing
hydrophilic proteins was carefully separated from
the lower detergent-rich phase containing hydropho-
bic proteins. Both fractions were diluted with water
to a volume of 300 Wl, and subsequently the proteins
were precipitated as described above and submitted
to SDS-PAGE.
2.7. Treatment with deglycosylating enzymes
2.7.1. Neuraminidase (EC 3.2.1.18)
Brush-border membrane vesicles (500 Wg of pro-
tein) collected after photoa⁄nity labeling were sus-
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pended in 100 Wl of 20 mM sodium acetate bu¡er
(pH 5.5)/150 mM NaCl/10 mM CaCl2 and 100 Wl
(100 mU) of neuraminidase in the above bu¡er
were added. After 2 h incubation at 30‡C additional
100 mU of neuraminidase were added and incuba-
tion was performed for further 3 h. After dilution
with ice-cold 10 mM sodium phosphate bu¡er (pH
7.4)/4 mM PMSF/4 mM EDTA/4 mM iodoaceta-
mide the vesicles were collected by centrifugation
and membrane proteins were analyzed by SDS-
PAGE.
2.7.2. Endoglucosidase H (EC 3.2.1.96) and F
(EC 3.2.1.96), N-glycanase (EC 3.5.1.52)
Brush-border membrane versicles (500 Wg of pro-
tein) collected after photoa⁄nity labeling by centrif-
ugation were dissolved in 100 Wl of 1% Triton X-100
and incubated for 30 min at 4‡C. After centrifuga-
tion at 48 000Ug for 30 min, the clear supernatant
was heated to 90‡C for 5 min. After cooling and
addition of 100 Wl of 100 mM sodium phosphate
bu¡er (pH 6.1)/50 mM EDTA/1% Triton X-100/
0.1% SDS/1% 2-mercaptoethanol, 5 WU (5 Wl) of en-
Fig. 1. Direct photoa⁄nity labeling of rabbit small intestinal brush-border membrane vesicles with [3H]cephalexin. Brush-border mem-
brane vesicles from rabbit small intestine (150 Wg of protein) preloaded with 10 mM Tris/HEPES bu¡er (pH 7.4)/300 mM mannitol
were incubated for 5 min in the dark with 6.66 WM (2 WCi) [3H]cephalexin in 10 mM citrate/Tris bu¡er (pH 6.0)/140 mM KCl in the
absence or presence of 250 WM cefadroxil, 2 mM L-carnosine or 250 WM taurocholate and subsequently irradiated at 300 nm for
5 min. For comparison, brush-border membrane vesicles were also labeled with 0.47 WM (2 WCi) [3H]benzylpenicillin. After washing,
membrane proteins were separated by SDS-PAGE on 9% gels. After ¢xing and staining, the distribution of radioactivity was deter-
mined by liquid scintillation counting after slicing of the gels into 2-mm slices. The continuous line shows the distribution of Serva
Blue R-250-stained polypeptides, the dotted lines show the distribution of radioactivity.
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doglucosidase H, 1.7 U (2.5 Wl) of endoglucosidase F
or 0.9 U (7.2 Wl) of N-glycanase were added and after
12 h of incubation at 20‡C, proteins were precipi-
tated with chloroform/methanol and submitted to
SDS-PAGE.
2.8. Target size analysis
Irradiation was performed with high-energy elec-
trons from a 10-MeV linear accelerator at the Strah-
lenzentrum of the Justus-Liebig Universita«t, Giessen,
Germany. The cryotubes with the ileal brush-border
membrane vesicles were placed in the irradiation
chamber in front of the linear accelerator. Chamber
and samples were cooled with a stream of liquid N2
£owing through the chamber. The temperature was
kept constant in the range of 380 to 3130‡C, and
the actual temperature was measured with an elec-
trode placed within the chamber during irradiation.
After irradiation and die-down of induced radioac-
tivity, the samples were stored in liquid N2 and
transported back to the Hoechst laboratories. The
following day, the irradiated frozen samples were
opened and thawed at 37‡C. The vesicles were resus-
pended by passage through a 27-gauge syringe needle
and subsequently placed on ice. Samples of these
vesicles were then submitted to photoa⁄nity label-
ing. The functional molecular masses were calculated
from the empirical equation [35]
log Mr  5:893log D37;T30:0028T
where D37 is the radiation dosage in Mrad generating
37% of residual biological bio-activity compared with
controls and T the temperature (in ‡C).
3. Results
3.1. [3H]Cephalexin as a direct photoa⁄nity probe
for the H+/oligopeptide transporter
With photolabile derivatives of penicillins, cepha-
losporins and dipeptides, a membrane protein of Mr
127 000 was speci¢cally labeled and identi¢ed as a
prime candidate for the intestinal H/oligopeptide
transporter [5,6,12,13,17^20]. It was speculated that
an K-amino-cephalosporin with a chemical modi¢ca-
tion of the K-amino function by an 4-azido-[3,5-3H]-
benzoyl group would lead to a di¡erent labeling pat-
tern compared to the parent K-aminocephalosporin
with an intact K-amino function [36]. To investigate
this possibility, we have synthesized tritium-labeled
cephalexin for direct photoa⁄nity labeling. Owing
to the K,L-unsaturated carbonyl structure and gener-
ation of highly reactive radical intermediates via an
nCZ* activation upon irradiation with wavelengths
of 300^320 nm cephalosporins can be used for direct
photoa⁄nity labeling of cephalosporin binding pro-
teins as we have shown earlier [12,37]. Photoa⁄nity
labeling of rabbit brush-border membrane vesicles
with [3H]cephalexin resulted in an identical labeling
pattern as with the hitherto used photoprobes with a
speci¢c and prominent labeling of the 127-kDa pro-
tein (Fig. 1). Substrates of the H/oligopeptide trans-
porter, such as cefadroxil or L-carnosine, were able
to inhibit labeling of the [3H]cephalexin binding pro-
teins, whereas taurocholate had no e¡ect. Further-
more, also in brush-border membrane vesicles from
rat kidney cortex, identical proteins were labeled by
[3H]cephalexin and the other photoa⁄nity probes
(data not shown). These ¢ndings clearly indicate
that for the identi¢cation of putative H/oligopep-
tide transporters in mammalian small intestine and
kidney the radioactively labeled substrates benzylpe-
nicillin, cephalexin, 3-azidocephalexin, N-(4-azido-
benzoyl)-cephalexin and N-(4-azidobenzoyl)-glycyl-
L-proline are all well suited, since all of them bind
to the transporter ligand binding site. For practical
reasons concerning the availability of radiolabeled
compounds in high amounts and of high speci¢c ra-
dioactivity, most experiments described here were
performed with [3H]benzylpenicillin. In repeated ex-
periments with the other photoprobes, identical re-
sults were obtained.
3.2. Anatomical localization of the H+/oligopeptide
transporter along the duodenum^ileum axis.
To determine the anatomical localization of the
H/oligopeptide transporter along the duodenum^
ileum axis of the small intestine, brush-border mem-
brane vesicles from di¡erent regions of rabbit small
intestine were prepared to measure H/dependent
D-cephalexin uptake and to identify the oligopep-
tide/L-lactam antibiotic binding proteins by photoaf-
¢nity labeling. Fig. 2 (upper panel) shows that the
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H-dependent transport activity is present in all seg-
ments of the small intestine. Corresponding, photo-
a⁄nity labeling of the di¡erent membrane prepara-
tions revealed a speci¢c labeling of the 127-kDa
binding protein by [3H]benzylpenicillin in all seg-
ments (Fig. 2, lower panels). The labeling of the
127-kDa protein could be inhibited by the orally ac-
tive cephalosporins cephalexin and ce¢xime (data not
shown). Therefore, the intestinal nutrient transporter
for oligopeptides does not show as the D-glucose
transporter a strict regional localization to a distinct
anatomical site of the small intestine in contrast to
the Na/bile acid cotransporter [38] or the receptor-
mediated uptake system for vitamin B12 [39] which
are expressed exclusively in the terminal ileum.
3.3. Characterization of the oligopeptide/L-lactam
antibiotic binding proteins from rabbit small
intestine as integral and peripheral membrane
proteins
For a further characterization of the oligopeptide/
L-lactam antibiotic binding protein(s) phase separa-
tion experiments were performed to discriminate in-
tegral from peripheral membrane proteins. It was
previously shown that the photolabeled 127-kDa
binding protein can be completely solubilized by
non-ionic detergents, such as Triton X-100, n-octyl-
glucoside or CHAPS [19,23]. By treatment with so-
dium hydrogen carbonate at pH 10.5, a labeled poly-
peptide of Mr 120 000 was found in the supernatant,
whereas the majority of radioactivity remained in the
vesicle pellet (Fig. 3A). By phase separation experi-
ments with Triton X-114, the 127-kDa radiolabeled
protein was found in the detergent-rich phase (DRP)
indicating a hydrophobic integral membrane protein
(Fig. 3B). Interestingly, the majority of radiolabeled
proteins was always found in the detergent-poor
phase (DPP), possibly a consequence of the hydro-
philic nature of the respective proteins due to their
microheterogenous glycoprotein structure [23].
3.4. Enzymatic deglycosylation of the binding protein
for L-lactam antibiotics/oligopeptides
The broad band of the photolabeled 127-kDa pro-
tein on SDS-gels as well as the distribution of the
radiolabeled 127-kDa protein on two-dimensional
Fig. 2. Anatomical localization of H/D-cephalexin transport
and photoa⁄nity labeling of the H/oligopeptide transporter
along the duodenum^ileum axis in rabbit small intestine. Top:
the entire small intestine of rabbits was segmented into 8 pieces
of equal length, numbered 1^8, proximal to distal, and brush-
border membrane vesicles were prepared. For uptake measure-
ments, brush-border membrane vesicles (100 Wg of protein,
10 Wl) preloaded with 10 mM Tris/HEPES bu¡er (pH 7.4)/300
mM mannitol were incubated at 30‡C for 30 s with 90 Wl either
with 2 mM D-cephalexin in 10 mM citrate/Tris bu¡er (pH 6.0)/
140 mM KCl (open bars) or 20 mM Tris/HCl bu¡er (pH 7.4)/
140 mM NaCl (closed bars). Bottom: for photoa⁄nity labeling,
brush-border membrane vesicles (150 Wg of protein) of the 8
di¡erent small intestinal segments were incubated for 5 min in
the dark with 0.47 WM (2 WCi) [3H]benzylpenicillin and subse-
quently irradiated for 2 min at 254 nm. Afterwards, membrane
proteins were separated by SDS-PAGE and the distribution of
radioactivity was determined as described in legend to Fig. 1;
the numbers indicate the intestinal segments 1^8 from which
the brush-border membrane vesicles were prepared. Shown is
the distribution of radioactivity in the ¢rst 3 cm of each gel
track containing the 127-kDa protein.
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gels over a pH range of about 1 unit, as we have
shown previously [23], strongly argues for a micro-
heterogenous glycoprotein. Therefore, both brush-
border membrane vesicles or the puri¢ed 127-kDa
protein were treated with various deglycosylating en-
zymes. Treatment with neuraminidase had no e¡ect
Fig. 3. Phase separation experiments of rabbit small intestinal brush-border membrane vesicles after photoa⁄nity labeling with
[3H]benzylpenicillin. Rabbit small intestinal brush-border membrane vesicles (3.4 mg of protein) preloaded with 10 mM Tris/HEPES
(pH 7.4)/300 mM mannitol were incubated for 5 min in the dark with 0.5 WM (30 WCi) [3H]benzylpenicillin in 2.7 ml 10 mM citrate/
Tris bu¡er (pH 6.0)/140 mM KCl and subsequently irradiated for 2 min at 254 nm. After washing, the membrane vesicles were used
for the following biochemical examinations. (A) 1 mg of photolabeled brush-border membrane vesicles were suspended in 300 Wl of
100 mM sodium hydrogen carbonate solution/4 mM PMSF/4 mM iodoacetamide/4 mM EDTA and kept at 0‡C for 30 min. After
centrifugation at 48 000Ug for 30 min, the proteins in the resulting pellet and supernatant were analyzed by SDS-PAGE on 7.5%
gels. (B) 1.2 mg of photolabeled brush-border membrane vesicles were treated with Triton X-114 as described in Section 2 and pro-
teins in control vesicles and the Triton X-114 phases were separated by SDS-PAGE on 9% gels. DRP, detergent-poor phase contain-
ing hydrophilic proteins; DPP, detergent-rich phase containing hydrophobic proteins. All other conditions are as described in legend
to Fig. 1.
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on the molecular mass of the 127-kDa protein where-
as with endoglycosidases fragments of smaller molec-
ular mass were obtained. With endoglycosidase H a
band of Mr 115 000 was formed from the 127-kDa
protein, whereas with endoglycosidase F, two radio-
labeled bands of Mr 115 000 and 95 000 were formed
(Fig. 4A). In addition, the puri¢ed, photoa⁄nity-la-
beled 127-kDa protein could be degraded to a pro-
Fig. 4. Enzymatic deglycosylation of rabbit small intestinal brush-border membrane vesicles after photoa⁄nity labeling with
[3H]benzylpenicillin. (A) Rabbit small intestinal brush-border membrane vesicles were photolabeled as described in legend to Fig. 3. A
270 Wg amount of labeled membrane proteins was used as control and 670 Wg each was submitted to deglycosylation with endogluco-
sidase H or endoglycosidase F. All other conditions are according to Fig. 1. (B) The puri¢ed 127-kDa binding protein for oligopepti-
des/L-lactam antibiotics (250 Wl of eluate from Mono-S column, about 40 Wg of protein) was photoa⁄nity labeled with 0.5 WM (2.5
WCi) [3H]benzylpenicillin. Subsequently proteins were precipitated. The pellet was dissolved in 10 Wl of 0.5% SDS/0.1 M 2-mercapto-
ethanol and 6.5 Wl of this solution were submitted to deglycosylation with 7.2 Wl (0.9 U) of N-glycanase. After SDS-PAGE, the dis-
tribution of radioactivity was determined by liquid scintillation counting. The continuous lines shows the densitograms of stained
polypeptides, the dotted lines, the distribution of radioactivity. Upper graph: control. Lower graph: after deglycosylation with
N-glycanase.
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tein of Mr 95^100 000 with N-glycanase (Fig. 4B).
These studies con¢rm that the 127-kDa binding
protein for oligopeptides/L-lactam antibiotics from
rabbit small intestine is a microheterogenous glyco-
protein.
3.5. Copuri¢cation of the H/oligopeptide transport
system with the sucrase/isomaltase complex
The radiolabeled 127-kDa protein appears on SDS
gels in a molecular mass range where the ectoen-
zymes sucrase and isomaltase migrate. It can there-
fore a priori not be excluded that the photolabeled
127-kDa protein may be related to the sucrase/iso-
maltase complex. Thus we have puri¢ed the radio-
actively labeled 127-kDa protein from brush-border
membrane vesicles which have been photolabeled
with [3H]benzylpenicillin and have determined the
enzymatic activity of sucrase as well as the distribu-
tion pattern of the radiolabeled 127-kDa protein in
the individual chromatographic fractions. In wheat
germ lectin agarose chromatography as well as in
the subsequent cation exchange chromatography on
Mono-S columns, the distribution of the radiolabeled
127-kDa protein was parallel to the enzymatic activ-
ity of sucrase (Fig. 5), suggesting that the oligopep-
tide/L-lactam antibiotic binding protein copuri¢es
with the sucrase/isomaltase complex. In contrast,
the peptidase aminopeptidase N originally thought
to be directly associated with the peptide transporter
[40] could be separated from the 127-kDa photo-
labeled protein under these chromatographic condi-
Fig. 5. Puri¢cation of the 127-kDa binding protein for oligopeptides/L-lactam antibiotics from rabbit small intestinal brush-border
membrane vesicles after photoa⁄nity labeling with [3H]benzylpenicillin. Rabbit small intestinal brush-border membrane vesicles (3 mg)
preloaded with 10 mM Tris/HEPES bu¡er (pH 7.4)/300 mM mannitol were incubated with 0.83 WM (15 WCi) [3H]benzylpenicillin in
1 ml 10 mM citrate/Tris bu¡er (pH 6.0)/100 mM mannitol/100 mM KCl for 5 min in the dark at 30‡C and subsequently irradiated at
254 nm for 2 min. After washing, the ¢nal membrane pellet was suspended in 10 ml of 20 mM sodium acetate bu¡er (pH 4.5)/0.7%
n-octyl-glucoside and kept at 20‡C for 30 min. After centrifugation, the supernatant was applied to FPLC on a Mono-S HR 5/5 col-
umn using 20 mM sodium acetate bu¡er (pH 4.5)/0.7% n-octylglucoside as elution bu¡er and proteins were eluted by a NaCl-gradient
as indicated. Fractions of 1 ml were collected and aliquots were taken to measure the distribution of sucrase activity. From each frac-
tion, 200 Wl were removed, proteins were precipitated and submitted to SDS-PAGE on 7.5% gels. The bands containing the 127-kDa
protein were excised, proteins were digested with Biolute S and radioactivity was measured by liquid scintillation counting. 999, Ab-
sorption at 280 nm; W W W W W, shape of NaCl gradient; b-b-b-b, radioactivity in the 127-kDa bands; - - - - -, sucrase activity.
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tions [16]. All attempts to separate the sucrase/
isomaltase activity from the photolabeled 127-kDa
L-lactam antibiotic binding protein from brush-bor-
der membranes solubilized with the non-ionic deter-
gents n-octylglucoside or Triton X-100 using a
variety of chromatographic procedures [23] failed;
all fractions containing the photolabeled 127-kDa
protein also contained sucrase/isomaltase activity.
Polyclonal antibodies, raised against the puri¢ed
127-kDa protein were able to precipitate both, the
photolabeled 127-kDa protein and the sucrase activ-
ity (Fig. 6). The strict parallelity of radioactively la-
beled 127-kDa protein and sucrase activity in the
immunoprecipitate and the supernatant also strongly
suggests a de¢ned protein complex between sucrase/
isomaltase and the oligopeptide/L-lactam antibiotic
transporter. The 127-kDa protein puri¢ed by wheat
germ lectin agarose and cation exchange chromatog-
raphy on Mono-S columns to homogeneity as ana-
lyzed by SDS-PAGE could be functionally reconsti-
tuted into proteoliposomes exhibiting stereospeci¢c
reconstitution of D-cephalexin transport [20]. In these
proteoliposomes, sucrase activity could be measured
supporting the assumption of a complex between the
oligopeptide transporter and sucrase. Chemical
crosslinking with bifunctional agents is a valuable
tool to identify the neighborhood of proteins and
the subunit composition of protein complexes. With
bifunctional reagents, such as dimethylsuberimidate,
bissuccinimidylsuberate (BSS) or bisulfosuccinimidyl
suberate (BS3), high molecular mass protein products
stacking at the start of the concentration gel (gel
concentration 4%) or the separation gel (gel concen-
tration 6%) were formed, indicating protein com-
plexes with molecular masses s 600 kDa. However,
by variation of the pH, the duration of the cross-
Fig. 6. Immunocoprecipitation of the 127-kDa binding protein for oligopeptides/L-lactam antibiotics with sucrase activity. Rabbit
small intestinal brush-border membrane vesicles (1 mg of protein) were photolabeled with 2.2 WM (20 WCi) [3H]benzylpenicillin. After
washing, membrane proteins were solubilized by resuspension of the membrane vesicles in 500 Wl of 10 mM sodium phosphate bu¡er/
1% Triton X-100 at 4‡C for 30 min. After centrifugation and separation of non-solubilized proteins, to 85 Wl of supernatant (contain-
ing solubilized membrane proteins, 170 Wg of protein, 5, 10, 25 or 50 Wl of antiserum raised against the puri¢ed 127-kDa protein
[19,23] were added in a total volume of 250 Wl. After 60 min at 4‡C, the samples were centrifuged and separated into supernatant and
pellet. The pellets were resuspended in 100 Wl of 1% Triton X-100. Aliquots of 7 Wl from the supernatants and 40 Wl aliquots from
the solubilized pellet material were used for the determination of sucrase activity and measurement of radioactivity by liquid scintilla-
tion counting. b, Radioactivity in the immunoprecipitate; a, sucrase activity in the immunoprecipitate.
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linking reaction, the ratio of crosslinker and protein
(both, with membrane vesicles and puri¢ed 127-kDa
protein), the protein complexes with molecular
masses between the monomeric 127-kDa protein
and the high molecular mass aggregates not could
be captured. This suggests a covalent crosslinking
between individual protein complexes rather than be-
tween the subunits of an individual protein complex.
To investigate a possible direct involvement of su-
crase/isomaltase in the transport of oligopeptides/
L-lactam antibiotics, the in£uence of a glucosidase
inhibitor, HOE 120, on H-dependent uptake of
D-cephalexin by small intestinal brush-border mem-
brane vesicles and photoa⁄nity labeling of the 127-
kDa protein was investigated. Fig. 7 shows that the
enzymatic activity of sucrase and isomaltase in rabbit
brush-border membrane vesicles was concentration-
dependently inhibited by HOE 120 with IC50 values
of 0.13 and 11 WM, respectively. The transport activ-
ities of the H/oligopeptide transporter, the Na-de-
pendent transport systems for bile acids and D-glu-
cose as well as the enzymatic activity of
aminopeptidase N were not a¡ected by HOE 120.
Photoa⁄nity labeling of the 127-kDa protein by
[3H]benzylpenicillin was also not in£uenced by the
presence of HOE 120 (data not shown). Further-
more, HOE 120 also had no in£uence on transport
or photoa⁄nity labeling of the H/oligopeptide
transporter in proteoliposomes, prepared either
from solubilized brush-border membrane protein or
from the puri¢ed 127-kDa protein (data not shown).
The ¢ndings that the puri¢ed 127-kDa protein was
homogeneous, according to SDS-PAGE, and that
the glucosidase inhibitor HOE 120 completely inhib-
ited sucrase activity with no in£uence on D-cephalex-
in transport in proteoliposomes, further supports the
assumption that the puri¢ed 127-kDa protein exhib-
its H-dependent oligopeptide transport as well as
sucrase/isomaltase activity.
3.6. Target size analysis of the 127-kDa binding
protein for oligopeptides/L-lactam antibiotics
Since the 127-kDa binding protein for oligopepti-
des/L-lactam antibiotics is puri¢ed as a protein com-
plex, radiation-inactivation studies were performed
Fig. 7. E¡ect of the glucosidase inhibitor HOE 120 on the uptake of D-cephalexin, taurocholate and D-glucose and on the enzymatic
activity of sucrase, isomaltase and aminopeptidase N. Brush-border membrane vesicles from rabbit small intestine suspended in 10 mM
Tris/HEPES bu¡er (pH 7.4)/300 mM mannitol were incubated with the indicated concentrations of the glucosidase inhibitor HOE 120
and subsequently H-dependent D-cephalexin uptake, Na-dependent taurocholate and D-glucose transport as well as the enzymatic
activities of sucrase, isomaltase and aminopeptidase N were measured as described. The respective activities are expressed as percent-
age of controls measured in the absence of HOE 120. b, Sucrase; U, isomaltase; a, aminopeptidase N; F, cephalexin transport; +,
taurocholate transport; W, D-glucose transport.
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to determine the functional molecular mass of the
oligopeptide transporter for binding of ligands.
Under conditions where, in the irradiated brush-bor-
der membrane vesicles, the correct functional molec-
ular mass of the brush-border enzymes aminopepti-
dase N and sucrase, as well as of the Na/D-glucose
transporter and the Na/taurocholate cotransporter
could be determined, no radiation dose-dependence
of the H-dependent D-cephalexin uptake (2 mM,
uptake after 20 s, 60 s and 60 min) could be ob-
served. The reason for this failure remains unclear.
In contrast, the functional molecular mass of the H/
oligopeptide transporter from rat kidney was deter-
mined to 416 þ 16 kDa [41]. To identify the function-
al molecular mass of the 127-kDa binding protein for
binding of ligands, photoa⁄nity labeling with
[3H]benzylpenicillin was performed with the radia-
tion-inactivated brush-border membrane vesicles.
From six independent experiments, a functional mo-
lecular mass of 165 þ 17 kDa (D37 value 9.16 þ 0.9
Mrad) was found for the 127-kDa binding protein
(Fig. 8). The carbohydrate content of a membrane
protein usually does not contribute to the functional
molecular mass of a protein or protein complex as
was demonstrated by Kempner and coworkers [42].
A molecular mass of 95 kDa was obtained from the
photolabeled 127-kDa protein after treatment with
endoglycosidase F. Two subunits of Mr 95 kDa
would give a molecular mass of 190 kDa which is
close to the measured molecular mass of 165 þ 17
kDa.
Interestingly, the binding of bile acids to the 93-
kDa subunit of the Na/bile acid cotransporter from
rabbit ileum [43] as well as to rat liver binding pro-
teins of Mr 48 and 54 kDa [44] also occurs to dimers
of the respective proteins. In contrast, for the H/
oligopeptide transporter from rat kidney the D37 val-
ues of 3.4 Mrad for the 105-kDa and 2.6 Mrad for
Fig. 8. Target size analysis of photoa⁄nity labeling of the 127-kDa binding proteins for oligopeptides/L-lactam antibiotics by
[3H]benzylpenicillin. Rabbit small intestinal brush-border membrane vesicles equilibrated with 10 mM Tris/HEPES bu¡er (pH 7.4)/300
mM mannitol/10 mM 2-mercaptoethanol were irradiated with the indicated doses of high-energy electrons. After photoa⁄nity labeling
with 0.44 WM (2 WCi) [3H]benzylpenicillin in 250 Wl 10 mM citrate/Tris bu¡er (pH 6.0)/140 mM KCl membrane proteins were sepa-
rated by SDS-PAGE and radioactivity in the 127-kDa band was determined by liquid scintillation counting after digestion of proteins
with Biolute S. The logarithm of residual labeling (100U (intensity of labeling after irradiation with dose X/intensity of labeling of
controls)%) of the 127-kDa band was plotted against radiation dose.
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the 130-kDa protein for photoa⁄nity labeling with
[3H]cefadroxil [41] correlate to functional molecular
masses s 414 kDa, suggesting at least tetrameric
structures for the kidney H/oligopeptide cotrans-
porter. This di¡erent behavior of the intestinal and
the kidney H/oligopeptide transporter supports our
previous conclusions that these transporters are re-
lated, but not identical [18,21], a ¢nding recently
con¢rmed by expression cloning of the H/peptide
cotransporter PEPT 2 from human kidney [29].
4. Discussion
A 127-kDa membrane protein was identi¢ed as a
component of the H/oligopeptide transporter from
rabbit small intestine by di¡erent approaches: (1)
photoa⁄nity labeling with photoreactive analogs
of cephalosporins, penicillins and dipeptides
[5,6,12,13,17^20]; (2) in di¡erential photoa⁄nity la-
beling studies the 127-kDa polypeptide showed an
identical substrate speci¢city as the transport system
[5,6,12]; (3) a⁄nity labeling with phenylisocyanate in
the absence and presence of cephalexin [12]; (4) pu-
ri¢cation of a radiolabeled 127-kDa protein from
intestinal brush-border membrane vesicles after pho-
toa⁄nity labeling of intact membrane vesicles with
photoreactive L-lactam antibiotics [19,23]; (5) func-
tional and stereospeci¢c reconstitution of oligopep-
tide transport activity after preparation of proteoli-
posomes from the puri¢ed 127-kDa protein [19,20];
and (6) a⁄nity chromatography puri¢cation of a
127- and a 117-kDa protein using a ceftibuten ^ ma-
trix and functional reconstitution of H-dependent
oligopeptide transport activity by incorporation of
the puri¢ed protein into proteoliposomes [24].
H-dependent transport activity was found in the
brush-border membrane of enterocytes of the entire
small intestine concomitantly with a speci¢c photo-
labeling of the 127-kDa protein by photoreactive L-
lactam antibiotics. By selective extraction and with
detergents, it was shown that the 127-kDa band con-
tained two photolabeled proteins of Mr 127 and 120
kDa. By enzymatic deglycosylation radiolabeled pro-
teins of Mr 115 and 95^100 kDa were obtained. Pu-
ri¢cation of the 127-kDa protein to homogeneity and
reconstitution into liposomes revealed that the lipo-
somes containing the 127-kDa protein were able to
transport the K-amino-L-lactam antibiotic cephalexin
stereospeci¢cally [12,20,23,24] ; both enantiomers
bind to the transporter [45], but only the D-enantio-
mer was transported [20], indicating the involvement
of the 127-kDa protein in the transport of oligopep-
tides and peptidomimetics across the intestinal
brush-border membrane. An involvement of mem-
brane-bound peptidases for the absorption of pep-
tides either by a multifunctional system or a protein
complex has been suggested [40], but no evidence for
the involvement of peptidases, such as aminopeptid-
ase N or dipeptidyl-peptidase IV, could be substan-
tiated [16,19]. However, the puri¢ed 127-kDa binding
protein for oligopeptides and L-lactam antibiotics
showed enzymatic activity of the sucrase/isomaltase
complex. It was shown that the photolabeled 127-
kDa L-lactam antibiotic binding protein copuri¢ed
with sucrase/isomaltase activity raising the question
whether the oligopeptide-transporting 127-kDa pro-
tein may be identical to the sucrase/isomaltase com-
plex. A very potent glucosidase inhibitor, HOE 120,
inhibited sucrase or isomaltase activity in the Wmolar
range, but neither had in£uence on H/D-cephalexin
cotransport nor on photoa⁄nity labeling of the 127-
kDa protein. Target-size analysis revealed a function-
al molecular mass of 105 þ 15 kDa for sucrase [43],
indicating that the enzymatic activity of sucrase is
independent of its tight binding to isomaltase or oth-
er proteins. A functional molecular mass of 165 þ 17
kDa for photoa⁄nity labeling of the 127-kDa pro-
tein is suggestive for a homo- or heterodimeric struc-
ture of the 127-kDa protein for binding of L-lactam
antibiotics.
A dual function of sucrase as an oligosaccharide-
degrading enzyme and as a transporter for oligopep-
tides/L-lactam antibiotics seems improbable. How-
ever, the membrane transporters for dibasic and neu-
tral amino acids from rat or rabbit kidney cortex are
78-kDa membrane proteins with only one transmem-
brane segment showing a high similarity of the ex-
tracellular domain with glucosidases [46,47]. Two
models for the structure of these transporters are
discussed: either an oligomerization to form a func-
tional transporter with multiple transmembrane re-
gions or modulation of the transporter site by a glu-
cosidase-like protein [46]. The strong inhibition of
sucrase activity by the disaccharidase inhibitor
HOE 120 without any e¡ect on cephalexin transport
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or photoa⁄nity labeling of the 127-kDa protein both
in brush-border membrane vesicles as well as in re-
constituted proteoliopsomes ^ makes the latter pos-
sibility for the H/oligopeptide transporter/sucrase/
isomaltase complex unlikely. The relationship of
the 127-kDa oligopeptide-binding protein described
by us and Miyazaki and coworkers [24,25] to the two
structurally completely di¡erent H/oligopeptide
transporters PepT1 and HPT-1 from the small intes-
tine identi¢ed by di¡erent cloning strategies
[26,28,48] remains unclear. The reduction of the mo-
lecular masses by deglycosylation to proteins of Mr
78 kDa in the rat [24] and 95 kDa in the rabbit may
indicate that the puri¢ed 127-kDa protein contains a
glycosylated form of the oligopeptide transporter
PepT1 which codes for a protein of Mr 79 kDa
[24]. Our ¢ndings as well as those of Miyazaki and
coworkers [24,25] strongly suggest that the H/oligo-
peptide transport system isolated from intestinal
brush-border membrane vesicles is isolated as a pro-
tein complex composed of several protein species.
Preliminary experiments using chemical and enzy-
matic degradation with the puri¢ed 127-kDa protein
showed that the 127-kDa protein, being homogene-
ous on SDS-gels, contained sequence fragments of
sucrase, isomaltase and a hitherto unknown protein
of Mr 127 kDa being not related to the Pep T1 [26]
or HPT-1 transporters [28]. It may well be that a
functional transport system isolated from intact tis-
sue has a di¡erent subunit composition compared to
the transporter functionally expressed by transfection
of cells or injection of the respective cDNA into oo-
cytes. Identi¢cation of transporters by expression
cloning buries the risk, that the mRNA fraction giv-
ing the highest signal is ampli¢ed leading to the iden-
ti¢cation of the respective transporter protein. Addi-
tional transport systems with lower transport activity
may escape their identi¢cation. The successful ex-
pression cloning of a transporter gives no conclusive
information about its physiological contribution and
involvement. It is interesting to note that proteins of
completely di¡erent sequence and structure, but sim-
ilar or identical function, have been identi¢ed in the
liver. The Na/bile acid cotransporter (NTCP) was
identi¢ed by expression cloning with ligand uptake
measurements in transfected oocytes [49], whereas a
Na/bile acid cotransporter identical with microso-
mal epoxide hydrolase was identi¢ed by transport
inhibition with monoclonal antibodies [50]. Further-
more, a transporter protein expressed in a transgenic
cell line, may not fully re£ect the behavior of the
functional transport system in vivo. For example,
the Na/D-glucose transporter SGLT1 [51] unambig-
uously exerts Na/D-glucose cotransport. There is,
however, increasing evidence that a further 70-kDa
protein modulates the activity of SGLT 1 in vivo
[52]. Similarly, ileal bile acid absorption is mediated
by a 7-transmembrane domain transporter of 348 or
347 amino acids [53]. By di¡erent approaches, we
could demonstrate that in rabbit ileal brush-border
membrane vesicles, the activity of this transporter
protein is modulated by interaction with a cyto-
plasmically attached 14-kDa lipid binding protein
[54,55]. Further studies are necessary to identify the
role of the 127-kDa L-lactam antibiotic/oligopeptide
binding protein and sucrase/isomaltase for H-de-
pendent oligopeptide transport in rabbit intestinal
brush-border membrane vesicles.
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